Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6220
Source ID: NCT02150707
Associated Drug: Dipeptidyl-Peptidase Iv Inhibitors
Title: The Differential Effects of Diabetes Therapy on Inflammation
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetic Nephropathy|Type 2 Diabetes
Interventions: DRUG: Dipeptidyl-Peptidase IV Inhibitors|DRUG: Glucagon-Like Peptide 1
Outcome Measures: Primary: Monocyte:chemoattractant protein 1 (MCP-1):creatinine ratio, 6 months | Secondary: Albumin:creatinine ratio, 6 months
Sponsor/Collaborators: Sponsor: University College Dublin | Collaborators: Irish Endocrine Society|Royal College of Physicians|Merck Sharp & Dohme LLC|Eli Lilly and Company
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 17
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2014-05
Completion Date: 2015-12
Results First Posted:
Last Update Posted: 2016-05-18
Locations: Mater Misericordiae University Hospital, Dublin, Dublin 7, Ireland
URL: https://clinicaltrials.gov/show/NCT02150707